CASU, Gavino
 Distribuzione geografica
Continente #
AS - Asia 3.401
NA - Nord America 3.332
SA - Sud America 2.522
EU - Europa 1.148
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 10.549
Nazione #
US - Stati Uniti d'America 3.172
BR - Brasile 2.252
SG - Singapore 1.886
CN - Cina 512
IT - Italia 382
HK - Hong Kong 323
DE - Germania 199
VN - Vietnam 198
AR - Argentina 94
UA - Ucraina 84
FI - Finlandia 71
RU - Federazione Russa 70
CA - Canada 68
GB - Regno Unito 66
TR - Turchia 66
MX - Messico 57
EC - Ecuador 54
FR - Francia 51
IN - India 51
BD - Bangladesh 50
IQ - Iraq 50
UZ - Uzbekistan 43
ZA - Sudafrica 41
SE - Svezia 37
AT - Austria 35
VE - Venezuela 34
NL - Olanda 31
JP - Giappone 29
CO - Colombia 25
KR - Corea 24
MA - Marocco 22
PK - Pakistan 22
PL - Polonia 22
KE - Kenya 20
CZ - Repubblica Ceca 19
ES - Italia 19
PY - Paraguay 18
ID - Indonesia 17
PE - Perù 17
JO - Giordania 14
KZ - Kazakistan 14
TN - Tunisia 14
AZ - Azerbaigian 13
NP - Nepal 13
CL - Cile 12
DZ - Algeria 12
LT - Lituania 12
AE - Emirati Arabi Uniti 10
UY - Uruguay 10
BE - Belgio 8
EG - Egitto 8
SA - Arabia Saudita 8
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
LB - Libano 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 7
JM - Giamaica 6
AL - Albania 5
IL - Israele 5
PH - Filippine 5
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
HU - Ungheria 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
BH - Bahrain 3
CG - Congo 3
CR - Costa Rica 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
KW - Kuwait 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
SI - Slovenia 3
AO - Angola 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CI - Costa d'Avorio 2
IR - Iran 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
Totale 10.536
Città #
Dallas 1.966
Singapore 1.023
Hong Kong 321
Beijing 212
Ashburn 175
São Paulo 169
Shanghai 113
Los Angeles 74
Munich 71
Ho Chi Minh City 70
Chandler 67
Belo Horizonte 66
Rio de Janeiro 64
Santa Clara 60
New York 54
Hanoi 45
Brasília 42
Curitiba 42
Helsinki 41
Tashkent 37
Nuremberg 35
Jacksonville 33
Porto Alegre 33
Boardman 27
Tokyo 27
Campinas 26
Romola 26
Orem 25
Brooklyn 24
Johannesburg 24
Seoul 24
Frankfurt am Main 23
Montreal 23
Sassari 23
Baghdad 22
Princeton 22
Tianjin 22
Ribeirão Preto 21
Rome 21
Warsaw 21
Ann Arbor 20
Düsseldorf 20
Guayaquil 20
Milan 20
Salvador 20
Boston 19
Denver 19
Nairobi 19
Wilmington 19
Guarulhos 18
Quito 17
Vienna 17
Falkenstein 16
Istanbul 16
Santo André 16
Stockholm 16
Toronto 16
Uberlândia 16
Chennai 15
London 15
Belford Roxo 14
Buenos Aires 14
Lima 14
Sorocaba 14
Amman 13
Baku 13
Betim 13
Cagliari 13
Dearborn 13
Juiz de Fora 13
Nanjing 13
Amsterdam 12
Atlanta 12
Brno 12
Gravataí 12
Mauá 12
São José dos Campos 12
Turku 12
Ankara 11
Aracaju 11
Canoas 11
Caracas 11
Dhaka 11
Fortaleza 11
Goiânia 11
Houston 11
João Pessoa 11
Mexico City 11
Poplar 11
Asunción 10
Campo Grande 10
Franca 10
Joinville 10
Jundiaí 10
Lappeenranta 10
Manaus 10
San Francisco 10
San Jose 10
Campos dos Goytacazes 9
Columbus 9
Totale 6.028
Nome #
Left atrial appendage occlusion: behind the bleeding risk 213
Left Atrial Appendage Closure vs. Oral Anticoagulation: still a matter of debate 157
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 157
Brain anticipatory cardiovascular responses to exercise 147
Permanent pacemaker dependency after transcatheter aortic valve implantation: Prevalence, patients’ characteristics, and main determinants 139
Albumina plasmatica come indice prognostico nei pazienti con ictus cerebrale ischemico. 134
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 121
Follicular spicules and multiple ulcers: cutaneous manifestations of multiple myeloma 119
Aging of the Arterial System 116
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists 112
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry 110
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 108
Diagnosis of Brugada syndrome affects quality of life and psychological status 106
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 104
Spicule follicolari del volto: una manifestazione cutanea peculiare del mieloma multiplo con crioglobulinemia 101
Integrating Pharmacological Features to Personalized Models With Statin Therapy 101
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: Indications, patient selection, competences, organization, and operator training 99
Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials 98
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 97
Association of chromosome 9p21 with subsequent coronary heart disease events: A GENIUS-CHD study of individual participant data 96
Serum albumin and mortality risk in old patients with acute ischemic stroke. 95
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 94
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint 93
Cerebral amyloid angiopathy and atrial fibrillation: a dangerous combination 91
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: Indications, patient selection, staff skills, organisation, and training 88
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy: Insights From the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 87
Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry 86
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: A webthal study 85
Clinical application of virtual reality in patients with cardiovascular disease: state of the art 84
Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome 84
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2021), 34, 1, (63-73), 10.1007/s40620-020-00774-5) 83
"A heterozygous mutation of the elastin gene ( ELN: p.val154met) fully co-segregates with classic marfan phenotype in a sardinian family: a possible novel disease-gene?" 82
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion 82
Ictus cerebale ischemico e infiammazione: nuovi indici di prognosi. 82
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 81
Effect of rhTSH on Lipids 80
Abstract 110: Quality of life in Beta Thalassemia 80
Integration of “Omics” Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome 78
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension 78
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 77
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 77
An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: heartguardai 77
Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: Acute results of the FLAI study 76
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials 75
A double left anterior descending coronary artery emerging from the right Valsalva sinus: A case report and a brief literature review 74
Antegrade fenestration and re-entry for bailout treatment of iatrogenic coronary dissection 74
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 74
Atrial Fibrillation in Patients Undergoing Transcatheter Mitral Valve Repair: More Than Meets the Eye? 74
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study 73
Allergic Myocardial Infarction: An Unusual Cause of Stent Thrombosis 72
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension 72
Virtual reality and cardiac rehabilitation: a new middle-range theory to outline its mechanism of effectiveness 71
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 71
Improving adherence to rehabilitation for heart failure patients through immersive virtual reality (VIRTUAL-HF): A protocol for a randomized controlled trial 71
Anomalous origin of right coronary artery from left sinus of valsalva 70
Highly specialized stroke care improves the 30-day survival 70
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment 69
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device 69
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 69
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 69
Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study 68
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 68
Correspondence 68
Vascular assisted-tracking for challenging transradial percutaneous intervention 68
The experience of immersive virtual reality in patients with heart failure during cardiac rehabilitation: a qualitative study 68
Spontaneous Retrograde Embolization From an Infarct-Related Artery to a Bystander Nonculprit Artery: An Unclear Pathophysiological Mechanism? 66
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial 66
Letter to the editor 66
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus 66
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 65
Diuretic therapy in heart failure - Current approaches 64
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 64
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies 63
Theoretical basis for a new approach of studying Emery-Dreifuss muscular dystrophy by means of thermography 63
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 63
Subsequent Event Risk in Individuals With Established Coronary Heart Disease 63
Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics 61
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 61
EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder 61
Computed Tomography and Frailty Assessment in Transcatheter Aortic Valve Implantation Candidates: Can We Kill Two Birds With One Stone? 61
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis 60
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension 60
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 60
Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study 60
Safety and efficacy of a light antithrombotic regimen after left atrial appendage occlusion: Insights from the LOGIC (left atrial appendage occlusion in patients with gastrointestinal or IntraCranial bleeding) international multicenter registry 60
Prevalence of the RR genotypes of the locus ACTN3-R577X in Italian Muay Thai elite fighters 59
The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective 59
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 59
Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing 59
Impact of Selection Bias on Estimation of Subsequent Event Risk 59
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study 58
Does the age affect the outcomes of cardiac resynchronization therapy in elderly patients? 58
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 58
Inside the “Razor Effect”: Lessons From Optical Coherence Tomography—What Does Angiography Hide? 58
The Italian registry of renal denervation 57
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2) 57
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry 57
Brugada phenocopy in a patient with unstable angina and three-vessel coronary artery disease 56
Novel Perspectives on Genetic Evaluation in Early-Onset Atrial Fibrillation: Clinical Implications and Future Directions 56
Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator 56
Totale 8.031
Categoria #
all - tutte 41.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 6 11 0 12 15 6 2
2021/202247 9 0 2 1 0 1 1 2 5 1 5 20
2022/2023119 16 12 7 20 7 18 0 12 19 2 5 1
2023/2024493 12 2 1 2 11 4 5 187 0 17 80 172
2024/20254.896 16 91 292 132 172 200 258 856 1.786 730 211 152
2025/20264.932 322 1.662 752 1.077 808 311 0 0 0 0 0 0
Totale 10.760